<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Creamer A</submitter><funding>EPSRC Centre for Doctoral Training in Neurotechnology</funding><funding>Cancer Research UK</funding><funding>LifeArc</funding><funding>Kreftforeningen</funding><funding>Wolfson Foundation</funding><funding>Royal Academy of Engineering Chair in Emerging Technologies</funding><funding>EPSRC</funding><funding>University College London</funding><funding>European Commission</funding><funding>Institute of Cancer Research</funding><funding>Engineering and Physical Sciences Research Council</funding><funding>EPSRC IRC Agile Early Warning Sensing Systems for Infectious Diseases and Antimicrobial Resistance</funding><funding>Norges Forskningsrådet</funding><funding>NFR</funding><funding>AffibodyAB</funding><funding>H2020 Excellent Science</funding><funding>EC</funding><funding>Leverhulme Trust</funding><funding>Rosetrees</funding><funding>UK Regenerative Medicine Platform</funding><funding>Royal Society</funding><funding>Rosetrees Trust</funding><funding>Aker Scholarship</funding><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><funding>EPRSC and SFI Centre for Doctoral Training in Advanced Characterisation of Materials</funding><pagination>e2300413</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7616993</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(20)</volume><pubmed_abstract>Semiconducting polymer nanoparticles (SPNs) are explored for applications in cancer theranostics because of their high absorption coefficients, photostability, and biocompatibility. However, SPNs are susceptible to aggregation and protein fouling in physiological conditions, which can be detrimental for in vivo applications. Here, a method for achieving colloidally stable and low-fouling SPNs is described by grafting poly(ethylene glycol) (PEG) onto the backbone of the fluorescent semiconducting polymer, poly(9,9'-dioctylfluorene-5-fluoro-2,1,3-benzothiadiazole), in a simple one-step substitution reaction, postpolymerization. Further, by utilizing azide-functionalized PEG, anti-human epidermal growth factor receptor 2 (HER2) antibodies, antibody fragments, or affibodies are site-specifical</pubmed_abstract><journal>Advanced materials (Deerfield Beach, Fla.)</journal><pubmed_title>Modular Synthesis of Semiconducting Graft Copolymers to Achieve "Clickable" Fluorescent Nanoparticles with Long Circulation and Specific Cancer Targeting.</pubmed_title><pmcid>PMC7616993</pmcid><funding_grant_id>EP/S023259/1</funding_grant_id><funding_grant_id>EP/K031953/1</funding_grant_id><funding_grant_id>100063</funding_grant_id><funding_grant_id>209121</funding_grant_id><funding_grant_id>EP/L016737/1</funding_grant_id><funding_grant_id>EP/K020641/1</funding_grant_id><funding_grant_id>27886</funding_grant_id><funding_grant_id>314684</funding_grant_id><funding_grant_id>29385</funding_grant_id><funding_grant_id>M300-F2</funding_grant_id><funding_grant_id>EDDPMA-May21\100063</funding_grant_id><funding_grant_id>EP/R00529X/1</funding_grant_id><funding_grant_id>209121_Z_17_Z</funding_grant_id><funding_grant_id>EP/T517793/1</funding_grant_id><funding_grant_id>CiET2021/94</funding_grant_id><funding_grant_id>209121/Z/17/Z</funding_grant_id><funding_grant_id>EP/S023518/1</funding_grant_id><funding_grant_id>MR/R015651/1</funding_grant_id><funding_grant_id>M945</funding_grant_id><funding_grant_id>859458</funding_grant_id><funding_grant_id>EP/J021199/1</funding_grant_id><funding_grant_id>711091</funding_grant_id><funding_grant_id>PhD2022 100021</funding_grant_id><funding_grant_id>PhD2021 100022</funding_grant_id><funding_grant_id>275873</funding_grant_id><funding_grant_id>273319</funding_grant_id><funding_grant_id>1975550</funding_grant_id><pubmed_authors>de la Ballina LR</pubmed_authors><pubmed_authors>Hogset H</pubmed_authors><pubmed_authors>Shamsabadi A</pubmed_authors><pubmed_authors>Rochet LNC</pubmed_authors><pubmed_authors>Creamer A</pubmed_authors><pubmed_authors>Prados-Martin L</pubmed_authors><pubmed_authors>Kim N</pubmed_authors><pubmed_authors>Tang J</pubmed_authors><pubmed_authors>Bugeon L</pubmed_authors><pubmed_authors>Thanasi IA</pubmed_authors><pubmed_authors>Chudasama V</pubmed_authors><pubmed_authors>Kramer-Marek G</pubmed_authors><pubmed_authors>Dallman MJ</pubmed_authors><pubmed_authors>Love EA</pubmed_authors><pubmed_authors>Foote JEJ</pubmed_authors><pubmed_authors>Fenaroli F</pubmed_authors><pubmed_authors>Rapley CL</pubmed_authors><pubmed_authors>Heeney M</pubmed_authors><pubmed_authors>Turnock S</pubmed_authors><pubmed_authors>Stevens MM</pubmed_authors><pubmed_authors>Richards DA</pubmed_authors><pubmed_authors>Agliano A</pubmed_authors><pubmed_authors>Monahan A</pubmed_authors><pubmed_authors>Najer A</pubmed_authors><pubmed_authors>Wojciechowski JP</pubmed_authors><pubmed_authors>Fiego AL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Modular Synthesis of Semiconducting Graft Copolymers to Achieve "Clickable" Fluorescent Nanoparticles with Long Circulation and Specific Cancer Targeting.</name><description>Semiconducting polymer nanoparticles (SPNs) are explored for applications in cancer theranostics because of their high absorption coefficients, photostability, and biocompatibility. However, SPNs are susceptible to aggregation and protein fouling in physiological conditions, which can be detrimental for in vivo applications. Here, a method for achieving colloidally stable and low-fouling SPNs is described by grafting poly(ethylene glycol) (PEG) onto the backbone of the fluorescent semiconducting polymer, poly(9,9'-dioctylfluorene-5-fluoro-2,1,3-benzothiadiazole), in a simple one-step substitution reaction, postpolymerization. Further, by utilizing azide-functionalized PEG, anti-human epidermal growth factor receptor 2 (HER2) antibodies, antibody fragments, or affibodies are site-specifical</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2025-04-03T23:18:21.638Z</modification><creation>2025-04-03T23:18:21.638Z</creation></dates><accession>S-EPMC7616993</accession><cross_references><pubmed>36905683</pubmed><doi>10.1002/adma.202300413</doi></cross_references></HashMap>